期刊文献+

八种方案治疗霉菌性阴道炎的成本效果分析 被引量:2

Pharmacoeconomic analysis on 8 plans in the treatment of vaginal mycosis
下载PDF
导出
摘要 目的探讨4种治疗方案用于霉菌性阴道炎的药物经济学效果。方法选择2006年1月-2007年6月400例霉菌性阴道炎患者,随机分为8组:A组外用西药治疗,B组口服西药治疗,C组西药外用+口服治疗,D组外用中药治疗,E组内服中药治疗,F组中药外洗+内服治疗,G组外用西药+内服中药治疗,H组外用中药+内服西药治疗。应用药物经济学中成本-效果分析法是行评价。结果8种治疗方案总有效率分别为75.5%、52.0%、92.2%、75.O%、79.2%、94.0%、96.2%、94.0%;成本/效果(C/E)分别为1.7、0.36、1.6、1.2、.4.5、1.3、2.2、0.54;C、F、G、H组有效率在90%以上,以H组为参照,增加一个效果单位成本-效果比(△C/△E),分别为-5.1、342.5、74.9。结论A、B、D、E组治疗方法有效率低,H组治疗方案(中药外洗十口服氟康唑胶囊)最理想。 Objective To research the economic effect of eight plans for the treatment of vaginal mycosis. Methods Four hundred cases of vaginal mycosis were grouped as A, B, C, D, E, F, G, H at random. A : external use of western medicine ; B : oral use of western medicine;C :oral use of traditional Chinese medieine;F :external and oral use of traditional Chinese medicine; G: external use of western medicine and oral use of traditional Chinese medicine ; H : external use of traditional Chinese medicine and oral use of western medicine. Results The total effective rates in all the groups were 75.5% ,52.0% ,92.2% ,75. 0% ,79.2% ,94, 0% ,96.2% and 94.0% respectively C/E were 1.7,0.36,1.6,1.2,4.5,1.3,2.2 and 0.54 respectively. The total effective rates in groups over 90% were C,F,G,H. The △C/△E of A,B,D,E and H were -5.1,342.5,74. 9. Conclusion Group H ( external use of traditional Chinese medicine and oral use of fluconazole capsule ) is the optimal treatment.
出处 《淮海医药》 CAS 2009年第1期17-18,共2页 Journal of Huaihai Medicine
关键词 霉菌性阴道炎 药物经济学 成本 效果分析 Vaginal mycosis Pharmacoeconomics Cost Effect analysis
  • 相关文献

参考文献2

二级参考文献10

  • 1De Bernardis F,Lucciarini R,Boccanera M,et al.Phenotypic and functional characterization of vaginal dendritic cells in a rat model of Candida albicans vaginitis[].Infection and Immunity.2006
  • 2Giraldo PC,Babula O,Gon?alves AK,et al.Mannose-binding lectin gene polymorphism,vulvovaginal candidiasis,and bacte-rial vaginosis[].Obstetrics and Gynecology.2007
  • 3Fidel,PL,Barousse JrM,Espinosa T,et al.Live intravaginal Candida challenge in humans reveals newhypotheses for the im-munopathogenesis of vulvovaginal candidiasis[].Infection and Immunity.2004
  • 4Lian CH,and Liu WD.Differential expression ofCandida albicanssecreted aspartyl proteinase in human vulvovaginal can-didiasis[].Mycoses.2007
  • 5Nailis H,Coenye T,Van Nieuwerburgh F,et al.Development and evaluation of different normalization strategies for gene ex-pression studies inCandida albicansbiofilms by real-time PCR[].BMCMol Biol.2006
  • 6Sobel JD.Vulvovaginal candidosis[].The Lancet.2007
  • 7Wozniak KL,Palmer G,Kutner R,et al.Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis[].Medical Mycology.2005
  • 8LeBlanc DM,Barousse MM,and Fidel PL Jr.Role for Dendritic Cells in Immunoregulation during Experimental Vaginal Candidiasis[].Infection and Immunity.2006
  • 9Fei Liu,Qinping Liao,Zhaohui Liu et al.Mannose-binding lectin and vulvovaginal candidiasis[].International Journal of Gynecology & Obstetrics.2006
  • 10Nomanbhoy F,Steele C,Yano J,et al.Vaginal and oral epithelial cell anti-Candida activity[].Infection and Immunity.2002

共引文献14

同被引文献23

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部